(2018) reported that dietary supplementation of L-carnosine (500 mg/kg) resulted in decreased fasting glucose and HbA1c levels, as well as increased serum TG and HDL levels in patients with type 2 diabetes, without affecting IL-6 and IL-1β levels. The gene discussed is IL6; the disease is type 2 diabetes mellitus.